Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition

The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT.

Guardado en:
Detalles Bibliográficos
Autores principales: Na Zhao, Reid T. Powell, Xueying Yuan, Goeun Bae, Kevin P. Roarty, Fabio Stossi, Martina Strempfl, Michael J. Toneff, Hannah L. Johnson, Sendurai A. Mani, Philip Jones, Clifford C. Stephan, Jeffrey M. Rosen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4bf1f86424d4458c89d66da69cca86c8
record_format dspace
spelling oai:doaj.org-article:4bf1f86424d4458c89d66da69cca86c82021-12-02T17:01:29ZMorphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition10.1038/s41467-021-24545-32041-1723https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c82021-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-24545-3https://doaj.org/toc/2041-1723The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT.Na ZhaoReid T. PowellXueying YuanGoeun BaeKevin P. RoartyFabio StossiMartina StrempflMichael J. ToneffHannah L. JohnsonSendurai A. ManiPhilip JonesClifford C. StephanJeffrey M. RosenNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Na Zhao
Reid T. Powell
Xueying Yuan
Goeun Bae
Kevin P. Roarty
Fabio Stossi
Martina Strempfl
Michael J. Toneff
Hannah L. Johnson
Sendurai A. Mani
Philip Jones
Clifford C. Stephan
Jeffrey M. Rosen
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
description The epithelial-mesenchymal transition (EMT) has been implicated in stem cell properties and therapeutic resistance in cancer. Here, the authors show organoids derived from mesenchymal breast cancers exhibit a spikey structure which can be reverted and exploited for screening drugs that reverse EMT.
format article
author Na Zhao
Reid T. Powell
Xueying Yuan
Goeun Bae
Kevin P. Roarty
Fabio Stossi
Martina Strempfl
Michael J. Toneff
Hannah L. Johnson
Sendurai A. Mani
Philip Jones
Clifford C. Stephan
Jeffrey M. Rosen
author_facet Na Zhao
Reid T. Powell
Xueying Yuan
Goeun Bae
Kevin P. Roarty
Fabio Stossi
Martina Strempfl
Michael J. Toneff
Hannah L. Johnson
Sendurai A. Mani
Philip Jones
Clifford C. Stephan
Jeffrey M. Rosen
author_sort Na Zhao
title Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
title_short Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
title_full Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
title_fullStr Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
title_full_unstemmed Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
title_sort morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4bf1f86424d4458c89d66da69cca86c8
work_keys_str_mv AT nazhao morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT reidtpowell morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT xueyingyuan morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT goeunbae morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT kevinproarty morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT fabiostossi morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT martinastrempfl morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT michaeljtoneff morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT hannahljohnson morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT senduraiamani morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT philipjones morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT cliffordcstephan morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
AT jeffreymrosen morphologicalscreeningofmesenchymalmammarytumororganoidstoidentifydrugsthatreverseepithelialmesenchymaltransition
_version_ 1718382080191102976